FOLLICULAR LYMPHOMA FOUNDATION
OUR MISSION IS TO HELP THOSE WITH FOLLICULAR LYMPHOMA (FL), A CURRENTLY INCURABLE BLOOD CANCER, TO LIVE WELL AND GET WELL BY FINDING AND FUNDING THE BEST RESEARCH TO FIND BREAKTHROUGHS THAT WILL CHANGE HOW WE UNDERSTAND AND TREAT FL. WE PROVIDE FL FOCUSED INFORMATION RESOURCES FOR PATIENTS AND WORK TO ENSURE PATIENTS' VOICES ARE AT THE HEART OF THE SEARCH FOR BETTER TREATMENTS AND CURE.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net expenditure of £24,738 for the year ended 31 December 2024, resulting in total funds of £1,239,616. Per the trustees' report, unrestricted reserves of £1,102,542 significantly exceed the stated policy target of £500,000, and the trustees consider the going concern basis appropriate based on existing budgets and resources.
What the accounts disclose
“In the band £80,001 - £90,000 2”
“the Trustees have set a targeted reserves figure of £500k as at 31 December 2024.” — page 6
“During the period, the total aggregate amount of unrestricted donations from Trustees was £84,000 (2023: £71,700)” — page 29
Year-over-year changes
- Top pay band moved from £200,001 - £230,000 (FY2023) to £80,001 - £90,000 (FY2024).
Leadership, per the charity’s website
- Emma France — Global Chief Executive Officer
- Nicola Mendelsohn — Chair, UK and US Board
- Lord Jon Mendelsohn — UK and US Board
- Lord Richard Harrington — UK Board
- Andrea Wong — UK Board
- Mike Thompson — UK Board
- Professor Jonathan Simons — UK and US Board
- Jess Burley — UK Board
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Lady Nicola Sharon Mendelsohnchair
- Andrea Lynn Wong
- Jessica Jane Burley
- Jonathan Wilson Simons
- Lord Richard Irwin Harrington
- PETER MICHAEL VARDEY THOMPSON
- The Lord Jonathan Neil Mendelsohn
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £2.4m | £2.4m |
| 31/12/2023 | £2.1m | £2.0m |
| 31/12/2022 | £2.2m | £2.4m |
| 31/12/2021 | £1.7m | £636k |
| 31/12/2020 | £380k | £288k |
Common questions
Is FOLLICULAR LYMPHOMA FOUNDATION financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net expenditure of £24,738 for the year ended 31 December 2024, resulting in total funds of £1,239,616. Per the trustees' report, unrestricted reserves of £1,102,542 significantly exceed the stated policy target of £500,000, and the trustees consider the going concern basis appropriate based on existing budgets and resources. Its FY2024 accounts were audited by Cooper Parry Group Limited.
What does the highest-paid employee of FOLLICULAR LYMPHOMA FOUNDATION earn?
Per its FY2024 accounts, the highest-paid employee was in the £80,001 - £90,000 band.
Who funds FOLLICULAR LYMPHOMA FOUNDATION?
Funders whose own accounts filings name FOLLICULAR LYMPHOMA FOUNDATION as a grant recipient include THE MAURICE WOHL CHARITABLE FOUNDATION, THE CHARLES WOLFSON CHARITABLE TRUST, Blood Cancer UK Research, THE ERANDA ROTHSCHILD FOUNDATION, THE REGATTA FOUNDATION.
Shared trustees with funders
- The Lord Jonathan Neil Mendelsohn — trustee here and at THE CHARLES WOLFSON CHARITABLE TRUST
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE MAURICE WOHL CHARITABLE FOUNDATION | FY2022 | £400k | Medical Advancement |
| THE MAURICE WOHL CHARITABLE FOUNDATION | FY2021 | £400k | Medical Advancement |
| THE CHARLES WOLFSON CHARITABLE TRUST | FY2024 | £150k | Medicine |
| THE CHARLES WOLFSON CHARITABLE TRUST | FY2025 | £150k | Medicine |
| THE CHARLES WOLFSON CHARITABLE TRUST | FY2022 | £125k | Medicine |
| Blood Cancer UK Research | FY2024 | £87k | Research co-funding agreement |
| THE ERANDA ROTHSCHILD FOUNDATION | FY2022 | £50k | Health/welfare/medical research |
| THE REGATTA FOUNDATION | FY2025 | £50k | |
| THE BENSON AND LIONEL BLACK CHARITABLE TRUST | FY2023 | £50k | |
| THE REGATTA FOUNDATION | FY2022 | £50k | |
| THE UKI CHARITABLE FOUNDATION | FY2023 | £38k | |
| THE ERANDA ROTHSCHILD FOUNDATION | FY2023 | £20k | Health/welfare/medical research |
| RECHOV GORDON CHARITABLE TRUST | FY2022 | £3k | |
| RECHOV GORDON CHARITABLE TRUST | FY2024 | £2k | relief of poverty, advancement of Jewish religion and advancement of Jewish religious education |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE REED FOUNDATION | 2 | — |
| THE HOBSON CHARITY LIMITED | 2 | £12k |
| THE LANCASHIRE FOUNDATION | 2 | £10k |
| DRAGON CHRISTMAS CHARITY SALE | 2 | £2k |
| The Squire Patton Boggs Charitable Trust | 2 | £700 |
| WARRANT OFFICERS' & SERGEANTS' MESS SCHOOL OF ELECTRICAL & MECHANICAL ENGINEERS | 1 | — |
| THE ADRIAN SWIRE CHARITABLE TRUST | 1 | £100k |
| THE HELEN STRAKER CHARITY | 1 | £60k |
Charities like this
- THE INTERNATIONAL CML FOUNDATION
- THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION
- THE LILY FOUNDATION
- CHILDREN WITH CANCER UK
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- THE CO-OPERATIVE CLINICAL CANCER THERAPY TRUST FUND
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| FOLLICULAR LYMPHOMA FOUNDATION | £2.4m | £80,001 - £90,000 | — | unclear | — | no doubt |
| THE INTERNATIONAL CML FOUNDATION | £267k | £80,001 - £90,000 | 1 | unclear | 13.0% | no doubt |
| THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION | £508k | — | 0 | above | — | no doubt |
| THE LILY FOUNDATION | £1.1m | — | — | above | — | no doubt |
| CHILDREN WITH CANCER UK | £17.8m | £130,001 - £140,000 | — | unclear | 20.0% | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £502k | — | 0 | above | — | no doubt |